Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Technology Scientific & Technical Instruments
Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Therma Bright Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(319)
•••
Post by Watchman21on Mar 02, 2022 9:12am
144 Views
Post# 34474353

Fact of Current FDA EUA Covid19 Rapid Antigen Test - Per FDA

Fact of Current FDA EUA Covid19 Rapid Antigen Test - Per FDAWhat you all need to know about FDA EUA on COVID19 Rapid Antigen Tests - How Many Approved, How Many Test Variations, How Many Test for POC, How Many Tests for At Home Use, How Many Tests Are Nasal vs Saliva.

FDA EUA COVID19 Rapid Antigen Tests Granted Authorization https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2
  • Total: 27 Companies
  • Test Variations: 44 Variations
  • Point of Care EUA: 27 Companies / 44 variations (all can be used at PoC)
  • At Home Use EUA: 13 Companies / 16 variations
  • NASAL-BASED; 100% OF ALL TESTS.
  • SALIVA-BASED: NONE, NIL, ZERO, 0

Production: Not Keeping Up With Demand with Each Variant Spike

FDA EUA: World Class Standard, accepted by other nations

THRM WILL BE SITTING IN A CLASS OF ITS OWN

What more do retail shareholders need to know?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities